Studies have verified that the HER-2/neu (c-erbB-2) oncogene (located on chromosome 17) is amplified and overexpressed in many tumor types, and have compared these results with immunohistochemical expression and clinicopathological data using Tissue Microarray [16-20] or conventional slides [21-23]. Here, ERBB2 is linked to neoplasm.